维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="Fitoussi O"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Survival impact of rituximab combined with ACVBP and upfront consolidation auto-transplantation in high-risk diffuse large B-cell lymphoma for GELA显示文摘	Fitoussi O Belhadj K Mounier N	2011	Haematologica2011，96，8：	1
	2	Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA 显示文摘	Fitoussi O Belhadj K Mounier N	2011	Haematologica2011，96，8：	1
	3	Prospective evaluation of late cosmetic results following breast reconstruction: Implant reconstruction显示文摘	Clough KB O' Donoghue JM Fitoussi AD	2001	Plast Reconstr Surg2001，107，7：	1
	4	A phase II study of bortezomib in combination with intensied CHOP-like regimen ( ACVBP) in patients with previously untreated T-cell lymphoma: Results of the GELA LNH05-1 T trial显示文摘	Delmer A Fitoussi O Gaulard P	2009	J Clin Oncol2009，27，15：	1
	5	A phase2,multicentre,single-arm,open-label study to evaluate the safety and efficacy of single-agent lenalidomide(Revlimid)in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma:the EXPECT trial显示文摘	Morschhauser F Fitoussi O Haioun C	2013	Eur J Cancer2013，49，：	1
	6	A phase II study of borte- zomih in combination with intensified CHOP - like regimen (ACVBP) in patients with previously untreated T- cell lympho- ma:results of the GELA LNH05 - 1T trial 显示文摘	Delmer A Fitoussi O Gaulard P	2009	J Clinl Oncol2009，27，15：	1
	7	A phase 2,multicentre,single-arm,open-label study to evaluate the safety and efficacy of single-agent lenalidomide(Revlimid)in subjects with relapsed or refractory peripheral T-cell non-Hodgkinlymphoma:the EXPECT trial显示文摘	Morschhauser F Fitoussi O Haioun C	2013	Eur J Cancer2013，49，13：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费